Royal Bank of Canada Increases Abbott Laboratories (NYSE:ABT) Price Target to $128.00
Abbott Laboratories (NYSE:ABT – Get Free Report) had its price target lifted by research analysts at Royal Bank of Canada from $119.00 to $128.00 in a research report issued on Thursday, Benzinga reports. The firm presently has an “outperform” rating on the healthcare product maker’s stock. Royal Bank of Canada’s target price would suggest a […]
More Stories
BILL (NYSE:BILL) PT Raised to $62.00
BILL (NYSE:BILL – Free Report) had its price objective increased by Robert W. Baird from $60.00 to $62.00 in a...
StockNews.com Initiates Coverage on Chase (NYSE:CCF)
StockNews.com initiated coverage on shares of Chase (NYSE:CCF – Free Report) in a report published on Friday. The brokerage issued...
StockNews.com Initiates Coverage on Ambev (NYSE:ABEV)
StockNews.com assumed coverage on shares of Ambev (NYSE:ABEV – Free Report) in a report published on Friday morning. The firm...
Trevena (NASDAQ:TRVN) Coverage Initiated at StockNews.com
StockNews.com began coverage on shares of Trevena (NASDAQ:TRVN – Free Report) in a research report released on Friday morning. The...
Mesa Laboratories (NASDAQ:MLAB) Cut to “Hold” at StockNews.com
StockNews.com cut shares of Mesa Laboratories (NASDAQ:MLAB – Free Report) from a buy rating to a hold rating in a...
Global Self Storage (NASDAQ:SELF) Earns Buy Rating from Analysts at Alliance Global Partners
Alliance Global Partners assumed coverage on shares of Global Self Storage (NASDAQ:SELF – Free Report) in a research report released...